• Publications
  • Influence
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
PURPOSE To describe clinical features, therapeutic approaches, and prognostic factors in pediatric patients with atypical teratoid/rhabdoid tumors (ATRT) treated at St Jude Children's ResearchExpand
  • 227
  • 10
Pediatric extraadrenal paraganglioma.
BACKGROUND Pediatric paraganglioma is rare and extraadrenal paraganglioma has not been characterized in children. METHODS The authors reviewed the medical records and pathology samples of childrenExpand
  • 24
  • 2
Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial
This study investigates the outcome of children <10 years old with newly-diagnosed ependymoma treated on the prospective multinational “Head Start” III clinical trial. Between April 2004 and JulyExpand
  • 43
  • 2
Evaluation of IFN-gamma effects on apoptosis and gene expression in neuroblastoma--preclinical studies.
Loss of caspase-8 expression and resistance to cytotoxic agents occurs frequently in late stage neuroblastoma (NB). Interferon-gamma (IFN-gamma) induces caspase-8 in NB cells, sensitizing them toExpand
  • 43
  • 2
  • PDF
Choroid plexus tumors in adult and pediatric populations: the Cleveland Clinic and University Hospitals experience
Choroid plexus tumors (CPT) are rare neoplasms accounting for 1–4% of all pediatric brain tumors. They are divided into choroid plexus papilloma (CPP), atypical choroid plexus papilloma (APP) andExpand
  • 17
  • 1
Lumbar spinal atypical teratoid rhabdoid tumor
We describe a pediatric patient with an atypical teratoid rhabdoid tumor (AT/RT) exclusively of the lumbar spine, with a different presentation from the two previously reported pediatric lumbarExpand
  • 8
  • 1
Diffusion tensor imaging of intraaxial tumors at the cervicomedullary and pontomedullary junctions. Report of two cases.
Brainstem gliomas are a heterogeneous group of lesions that account for 15% of all pediatric tumors of the central nervous system. Diagnosis and treatment planning for these tumors is based on theExpand
  • 37
Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas
Current therapies for recurrent or progressive high-grade gliomas (HGG, WHO grade 3–4) produce a 6-month progression-free survival of only 10–25%. Migration and invasion by HGG is mediated in part byExpand
  • 25
Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies.
Archival slides are a potentially useful source of DNA for mutation analyses in large population-based studies. However, it is unknown whether specimen age or histological stains alter the accuracyExpand
  • 18
Role of high‐dose chemotherapy (HDCT) in treatment of atypical teratoid/rhabdoid tumors (AT/RTs)
Atypical teratoid/rhabdoid tumors (AT/RTs) of the CNS have been recently characterized as a distinct clinicopathologic entity with an unusually poor prognosis and with the highest incidence in theExpand
  • 8